Zydus Lifesciences Limited has successfully finalized its investment in Torrent Urja 25 Private Limited. Having previously invested in an initial tranche, the company and its subsidiaries contributed an additional Rs. 90.18 million on May 19, 2026. This final payment secures the subscription of 90,17,848 equity shares, effectively consummating the transaction and completing the strategic acquisition process initiated under the Share Subscription and Shareholders’ Agreement.
Consummation of Strategic Investment
Zydus Lifesciences Limited has reached a major milestone regarding its commitment to Torrent Urja 25 Private Limited. Following the initial agreement established in May 2025, the company has officially completed the subscription process for all four tranches of equity shares as of May 19, 2026.
Breakdown of Financial Commitment
The transaction concluded with a final investment of Rs. 90.18 million, which covers the shares allocated under Tranches 2, 3, and 4. This final installment accounted for the issuance of 90,17,848 equity shares. When combined with the earlier Tranche 1 investment of Rs. 38.65 million for 38,64,792 shares, the company has successfully fulfilled its obligations under the Share Subscription and Shareholders’ Agreement.
Impact on Equity Holding
This completed investment represents a 22.06% stake in the paid-up share capital of Torrent Urja 25. With the final tranches now processed, the transaction is fully consummated, marking the conclusion of this specific capital infusion phase for Zydus Lifesciences and its various participating subsidiaries.
Source: BSE
